Literature DB >> 25758364

Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease.

Sofia Reimão1,2, Patrícia Pita Lobo2,3,4, Dulce Neutel2,3, Leonor Correia Guedes2,3,4, Miguel Coelho2,3, Mário M Rosa2,3,5, Pedro Azevedo6, Joana Ferreira6, Daisy Abreu2, Nilza Gonçalves2, Rita G Nunes6, Jorge Campos1, Joaquim J Ferreira2,3,4,5.   

Abstract

BACKGROUND: Essential tremor (ET) is a very common movement disorder that has no diagnostic markers. Differentiation with Parkinson's disease (PD) can be clinically challenging in some cases, with a high rate of misdiagnosis. Magnetic resonance imaging (MRI) studies have been able to identify neuromelanin changes in the substantia nigra (SN) of PD patients, but they have thus far not been investigated in ET. In this study, we aimed to characterize neuromelanin-MR signal changes in ET and evaluate its diagnostic accuracy in the differential diagnosis with PD.
METHODS: The inclusion criteria were patients with ET and untreated "de novo" PD patients; in addition, age-matched controls were enrolled. These were studied with a high-resolution T1-weighted MRI sequence at 3.0 Tesla to visualize neuromelanin. The primary outcomes were the area and width of the SN region with high signal.
RESULTS: A total of 15 ET patients and 12 "de novo" PD patients were evaluated. The area and width of the T1 high signal in the SN region were markedly decreased in the PD group compared with the ET and age-matched controls, and a greater decrease was seen in the ventrolateral segment. The neuromelanin measures in the ET group, although slightly lower, were not significantly different from the healthy control group. We obtained a sensitivity of 66.7% and a specificity of 93.3% in discriminating ET from early-stage PD.
CONCLUSIONS: Neuromelanin-sensitive MRI techniques can discriminate ET from early-stage tremor-dominant PD and can be a useful clinical tool in the evaluation of tremor disorders.
© 2015 International Parkinson and Movement Disorder Society. © 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  MRI; Parkinson's disease; essential tremor; neuromelanin; substantia nigra

Mesh:

Substances:

Year:  2015        PMID: 25758364     DOI: 10.1002/mds.26182

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  28 in total

1.  No evidence of iron deposition in essential tremor: a susceptibility-weighted imaging study.

Authors:  Sara Pietracupa; Matteo Bologna; Silvia Tommasin; Francesca Elifani; Federica Vasselli; Giulia Paparella; Nikolaos Petsas; Alfredo Berardelli; Patrizia Pantano
Journal:  Neurol Sci       Date:  2021-03-15       Impact factor: 3.307

Review 2.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

3.  Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson's disease and factor analysis for its heterogeneity: a systematic review and meta-analysis.

Authors:  Se Jin Cho; Yun Jung Bae; Jong-Min Kim; Donghyun Kim; Sung Hyun Baik; Leonard Sunwoo; Byung Se Choi; Jae Hyoung Kim
Journal:  Eur Radiol       Date:  2020-09-04       Impact factor: 5.315

Review 4.  Role of Neuroimaging on Differentiation of Parkinson's Disease and Its Related Diseases.

Authors:  Toshihide Ogawa; Shinya Fujii; Keita Kuya; Shin-Ichiro Kitao; Yuki Shinohara; Mana Ishibashi; Yoshio Tanabe
Journal:  Yonago Acta Med       Date:  2018-09-26       Impact factor: 1.641

5.  Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited.

Authors:  Jason Langley; Daniel E Huddleston; Michael Merritt; Xiangchuan Chen; Rebecca McMurray; Michael Silver; Stewart A Factor; Xiaoping Hu
Journal:  Hum Brain Mapp       Date:  2016-03-29       Impact factor: 5.038

Review 6.  New Imaging Markers for Movement Disorders.

Authors:  Christine Ghadery; Antonio P Strafella
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-03       Impact factor: 5.081

Review 7.  MRI biomarkers of motor and non-motor symptoms in Parkinson's disease.

Authors:  Sephira G Ryman; Kathleen L Poston
Journal:  Parkinsonism Relat Disord       Date:  2019-10-10       Impact factor: 4.891

8.  Early-stage Parkinson's disease: Abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin-sensitive MRI.

Authors:  Young Hee Sung; Young Noh; Eung Yeop Kim
Journal:  Hum Brain Mapp       Date:  2021-03-10       Impact factor: 5.038

Review 9.  Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism.

Authors:  Nicola Pavese; Yen F Tai
Journal:  Mov Disord Clin Pract       Date:  2018-02-22

10.  Parkinson's disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI.

Authors:  Pierre Maquet; Gaëtan Garraux; Frédérique Depierreux; Eric Parmentier; Laurane Mackels; Katherine Baquero; Christian Degueldre; Evelyne Balteau; Eric Salmon; Christophe Phillips; Mohamed Ali Bahri
Journal:  NPJ Parkinsons Dis       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.